武汉大学中南医院心血管外科/心脏大血管外科微创诊疗湖北省工程研究中心/武汉市结构性心脏病微创诊疗临床医学研究中心 湖北 武汉 430071
丁柯晗,女,1996—,医学硕士,主要从事心脏疾病的发生及机制研究,E‑mail:dingkh2021@whu.edu.cn
赵金平,男,1960—,医学博士,教授,博士生导师,主要从事心脏及大血管疾病的发生及机制研究,E‑mail:zhaojinping@znhospital.cn
收稿:2024-03-20,
纸质出版:2025-06-25
移动端阅览
丁柯晗,王乐,余文军等.LMO7在阿霉素诱导的心脏扩张中的作用及机制[J].武汉大学学报(医学版),2025,46(06):716-722.
DING Kehan,WANG Le,YU Wenjun,et al.Role and mechanism of LMO7 in doxorubicin‑induced cardiac dilatation[J].Medical Journal of Wuhan University,2025,46(06):716-722.
丁柯晗,王乐,余文军等.LMO7在阿霉素诱导的心脏扩张中的作用及机制[J].武汉大学学报(医学版),2025,46(06):716-722. DOI: 10.14188/j.1671-8852.2024.0191.
DING Kehan,WANG Le,YU Wenjun,et al.Role and mechanism of LMO7 in doxorubicin‑induced cardiac dilatation[J].Medical Journal of Wuhan University,2025,46(06):716-722. DOI: 10.14188/j.1671-8852.2024.0191.
目的
2
探讨LMO7在阿霉素诱导的心脏扩张中导致心肌细胞凋亡的作用及机制,为阿霉素(DOX)心脏毒性的改善提供新思路。
方法
2
使用8周龄雄性小鼠,随机分为两组(
n
=7),一组腹腔注射4 mg·kg
-1
剂量的DOX构建心脏扩张疾病模型,另一组注射等体积的PBS溶液。5周后进行心脏超声检测后,获取小鼠心脏组织、Masson染色、LMO7免疫组化染色。蛋白印迹法(Western Blot)检测小鼠心脏LMO7、α‑SMA、Collagen Ⅰ、HSPA8、PI3K/p‑PI3K、AKT/p‑AKT的表达。体外实验:使用LMO7敲低腺病毒(Ad‑GFP‑SH LMO7)转染原代心肌细胞,分为对照组和LMO7敲低组。敲低组在不含血清的培养基中利用LMO7敲低腺病毒转染原代心肌细胞,12 h后使用含有1 μmol•L
-1
的DOX培养基(不含血清)换液,继续培养24 h后收取细胞;对照组则使用GFP对照腺病毒原代心肌细胞,步骤相同。检测LMO7、Caspase 9、Caspase 3、BAX/Bcl2、HSPA8、PI3K/p‑PI3K、AKT/p‑AKT的表达。采用
t
检验分析数据统计学差异。
结果
2
心脏超声显示相比于对照组小鼠,DOX注射5周后的小鼠心脏功能出现了明显的下降(
P
<
0.05),DOX注射小鼠心脏中LMO7、α‑SMA、Collagen Ⅰ、Caspase 9、Caspase 3、BAX/Bcl2表达显著增加(
P
<
0.05),免疫组化显示DOX注射组LMO7的含量显著高于对照组,Masson染色显示DOX注射组小鼠心脏中出现了大量的纤维化;相比于Ctrl组原代心肌细胞,DOX处理的原代心肌细胞中LMO7、Caspase 9、Caspase 3、BAX/Bcl2、HSPA8、p‑PI3K/PI3K、p‑AKT/AKT表达显著增加(
P
<
0.05);使用Ad‑GFP‑SH LMO7敲低LMO7后,相比于未敲低组,LMO7、Caspase 9、Caspase 3、BAX/Bcl2
、
表达显著降低(
P
<
0.05),HSPA8、p‑PI3K/PI3K、p‑AKT/AKT表达显著上升(
P
<
0.05)。
结论
2
LMO7的敲减会抑制阿霉素诱导的心脏扩张,其潜在机制可能是通过降低HSPA8含量来抑制PI3K‑AKT通路活化。
Objective
2
To investigate the role and mechanism of LMO7 in myocardial cell apoptosis in doxorubicin (DOX)‑induced cardiac dilatation
and to provide new ideas for improving the cardiotoxicity of DOX.
Methods
2
Eight‑week‑old male mice were randomly divided into two groups (
n
=7): One group was intraperitoneally injected with 4 mg·kg
-1
DOX to establish a dilated heart disease model(DOX injection group)
and the other group was injected with the same volume of PBS solution(control group). After 5 weeks
cardiac ultrasound was performed
and mouse heart tissues were collected for Masson staining and LMO7 immunohistochemical staining. Western Blot was used to detect the expression of LMO7
α‑SMA
Collagen Ⅰ
HSPA8
PI3K/p‑PI3K
and AKT/p‑AKT in mouse hearts.
In vitro
experiments: primary cardiomyocytes were transfected using LMO7 knockdown adenovirus (Ad⁃GFP⁃SH LMO7) and divided into control and LMO7 knockdown groups. In the knockdown group
primary cardiomyocytes were transfected with LMO7 knockdown adenovirus in serum⁃free medium for 12 h. After 12 h
the cells
were exchanged with DOX medium (serum⁃free) containing 1 μmol•L
-1
and the cells were harvested after 24 h of further incubation; in the control group
the primary cardiomyocytes were transfected with the GFP⁃control adenovirus using the same procedure. The expression of LMO7
Caspase 9
Caspase 3
BAX/Bcl2
HSPA8
PI3K/p‑PI3K
and AKT/p‑AKT was detected. Statistical analysis of the data was performed using a t‑test to analyze the statistical differences.
Results
2
The cardiac ultrasound revealed a significant decrease in cardiac function in mice after 5 weeks of DOX injection as compared with the control group (
P
<
0.05). The expression of LMO7
α‑SMA
Collagen Ⅰ
Caspase 9
Caspase 3
and BAX/Bcl2 in the hearts of the DOX injection group increased significantly (
P
<
0.05). Immunohistochemistry showed that the content of LMO7 in the DOX injection group was significantly higher than that in the control group. Masson's staining revealed extensive fibrosis in the hearts of mice in the DOX injection group. Compared with those in the control group
the expression of LMO7
Caspase 9
Caspase 3
BAX/Bcl2
HSPA8
p‑PI3K/PI3K
and as compared with those in the non‑knockdown cardiomyocyte ‑AKT/AKT increased significantly in primary cardiomyocytes of the DOX injection group (
P
<
0.05). After knocking down LMO7 using Ad‑GFP‑SH LMO7
the expression of LMO7
Caspase 9
Caspase 3
and BAX/Bcl2 significantly decreased(
P
<
0.05)
while the expression of HSPA8
p‑PI3K/PI3K
and p‑AKT/AKT significantly increased (
P
<
0.05).
Conclusion
2
Knockdown of LMO7 inhibits doxorubicin‑induced cardiac dilation
and its potential mechanism may involve reducing HSPA8 content to inhibit PI3K‑AKT pathway activation.
CARVALHO C , SANTOS R X , CARDOSO S , et al . Doxorubicin: The good, the bad and the ugly effect [J ] . Curr Med Chem , 2009 , 16 ( 25 ): 3267 ‑ 3285 .
YEH E T H , TONG A T , LENIHAN D J , et al . Cardiovascular complications of cancer therapy: Diagnosis, pathogenesis, and management [J ] . Circulation , 2004 , 109 ( 25 ): 3122 ‑ 3131 .
HORENSTEIN M S , VANDER HEIDE R S , L'ECUYER T J . Molecular basis of anthracycline‑induced cardiotoxicity and its prevention [J ] . Mol Genet Metab , 2000 , 71 ( 1/2 ): 436 ‑ 444 .
刘洁琼 , 姚雅俪 , 隋倩 , 等 . 沙库巴曲缬沙坦钠片预防多柔比星所致心脏毒性的机制 [J ] . 实用医学杂志 , 2024 , 40 ( 2 ): 188 ‑ 194 .
LIU J Q , YAO Y L , SUI Q , et al . Based on the novel anti‑heart failure drug ARNI, the mechanism of prevention of cardiotoxicity caused by anthracycline antitumor drugs was discussed [J ] . The Journal of Practical Medicine , 2024 , 40 ( 2 ): 188 ‑ 194 .
陈建溯 , 宋雅君 , 吴胜兰 , 等 . 利多卡因通过激活AMPK/SOCS3信号通路改善阿霉素引起的急性心肌损伤 [J ] . 南京医科大学学报(自然科学版) , 2023 , 43 ( 8 ): 1068 ‑ 1075 .
CHEN J S , SONG Y J , WU S L , et al . Lidocaine improves acute myocardial injury induced by Doxorubicin through activating AMPK/SOCS3 signaling pathway [J ] . Journal of Nanjing Medical University (Natural Science Edition) , 2023 , 43 ( 8 ): 1068 ‑ 1075 .
WEI S S , MA W J , LI X H , et al . Involvement of ROS/NLRP3 inflammasome signaling pathway in doxorubicin‑induced cardiotoxicity [J ] . Cardiovasc Toxicol , 2020 , 20 ( 5 ): 507 ‑ 519 .
NITISS J L . Targeting DNA topoisomerase Ⅱ in cancer chemotherapy [J ] . Nat Rev Cancer , 2009 , 9 ( 5 ): 338 ‑ 350 .
HAO E K , MUKHOPADHYAY P , CAO Z X , et al . Cannabidiol protects against doxorubicin‑induced cardiomyopathy by modulating mitochondrial function and biogenesis [J ] . Mol Med , 2015 , 21 ( 1 ): 38 ‑ 45 .
RENU K , ABILASH V G , TIRUPATHI PICHIAH P B , et al . Molecular mechanism of doxorubicin‑induced cardiomyopathy — An update [J ] . Eur J Pharmacol , 2018 , 818 : 241 ‑ 253 .
KONG P , CHRISTIA P , FRANGOGIANNIS N G . The pathogenesis of cardiac fibrosis [J ] . Cell Mol Life Sci , 2014 , 71 ( 4 ): 549 ‑ 574 .
TE VELTHUIS A J W , BAGOWSKI C P . PDZ and LIM domain‑encoding genes: Molecular interactions and their role in development [J ] . Sci World J , 2007 , 7 : 1470 ‑ 1492 .
OOSHIO T , IRIE K , MORIMOTO K , et al . Involvement of LMO7 in the association of two cell‑cell adhesion molecules, nectin and E‑cadherin, through afadin and alpha‑actinin in epithelial cells [J ] . J Biol Chem , 2004 , 279 ( 30 ): 3 1365‑ 31373 .
HU Q D , GUO C , LI Y L , et al . LMO7 mediates cell‑specific activation of the Rho‑myocardin‑related transcription factor‑serum response factor pathway and plays an important role in breast cancer cell migration [J ] . Mol Cell Biol , 2011 , 31 ( 16 ): 3223 ‑ 3240 .
DEDEIC Z , CETERA M , COHEN T V , et al . Emerin inhibits LMO7 binding to the Pax3 and MyoD promoters and expression of myoblast proliferation genes [J ] . J Cell Sci , 2011 , 124 ( Pt 10 ): 1691 ‑ 1702 .
WU TG , CHEN X , XU K Q , et al . LIM domain only 7 negatively controls nonalcoholic steatohepatitis in the setting of hyperlipidemia [J ] . Hepatology , 2024 , 79 ( 1 ): 149 ‑ 166 .
XIE Y , OSTRIKER A C , JIN Y , et al . LMO7 is a negative feedback regulator of transforming growth factor β signaling and fibrosis [J ] . Circulation , 2019 , 139 ( 5 ): 679 ‑ 693 .
LI C M , PENG Y , ZHOU B , et al . Association of LIM domain 7 gene polymorphisms and plasma levels of LIM domain 7 with dilated cardiomyopathy in a Chinese population [J ] . Appl Biochem Biotechnol , 2017 , 182 ( 3 ): 885 ‑ 897 .
ARRELL D K . Delineating RBM20 regulation of alternative splicing in dilated cardiomyopathy [J ] . Circ Cardiovasc Genet , 2014 , 7 ( 5 ): 732 ‑ 733 .
BI Y G , XU H X , WANG X , et al . FUNDC1 protects against doxorubicin‑induced cardiomyocyte PANoptosis through stabilizing mtDNA via interaction with TUFM [J ] . Cell Death Dis , 2022 , 13 ( 12 ): 1020 .
LI T , ZHANG Y S , WAN M , et al . Ganoderma atrum polysaccharide modulates the M1/M2 polarization of macrophages linked to the Notch signaling pathway [J ] . Food Funct , 2022 , 13 ( 7 ): 4216 ‑ 4228 .
XIA Y , CHEN Z W , CHEN A , et al . LCZ696 improves cardiac function via alleviating Drp1‑mediated mitochondrial dysfunction in mice with doxorubicin‑induced dilated cardiomyopathy [J ] . J Mol Cell Cardiol , 2017 , 108 : 138 ‑ 148 .
FOUAD A A , ALBUALI W H , AL‑MULHIM A S , et al . Cardioprotective effect of cannabidiol in rats exposed to doxorubicin toxicity [J ] . Environ Toxicol Pharmacol , 2013 , 36 ( 2 ): 347 ‑ 357 .
DOWD N P , SCULLY M , ADDERLEY S R , et al . Inhibition of cyclooxygenase‑2 aggravates doxorubicin‑mediated cardiac injury in vivo [J ] . J Clin Invest , 2001 , 108 ( 4 ): 585 ‑ 590 .
OUYANG L , SHI Z , ZHAO S , et al . Programmed cell death pathways in cancer: A review of apoptosis, autophagy and programmed necrosis [J ] . Cell Prolif , 2012 , 45 ( 6 ): 487 ‑ 498 .
SHARIATI M , MERIC‑BERNSTAM F . Targeting AKT for cancer therapy [J ] . Expert Opin Investig Drugs , 2019 , 28 ( 11 ): 977 ‑ 988 .
ICHIM G , TAIT S W G . A fate worse than death: Apoptosis as an oncogenic process [J ] . Nat Rev Cancer , 2016 , 16 ( 8 ): 539 ‑ 548 .
WU E P , HE W Y , WU C L , et al . HSPA8 acts as an amyloidase to suppress necroptosis by inhibiting and reversing functional amyloid formation [J ] . Cell Res , 2023 , 33 ( 11 ): 851 ‑ 866 .
COLOMBO A , CIPOLLA C , BEGGIATO M , et al . Cardiac toxicity of anticancer agents [J ] . Curr Cardiol Rep , 2013 , 15 ( 5 ): 362 .
0
浏览量
199
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621